This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Baker, C. Search for Related Content PubMed PubMed Citation Articles by Baker, C. Social Bookmarking                         What's this?

Serial Aspergillus Antigen Monitoring in Pediatric Bone Marrow Transplant Patients

Hackensack University Medical Center, Hackensack, NJ, courtneyebaker{at}yahoo.com

Invasive aspergillosis carries a high mortality rate in immunocompromised patients, such as bone marrow transplant patients. Favorable outcomes are dependent on early detection and treatment. Positive galactomannan antigenemia has been included as a microbiological criterion for probable or possible diagnosis of invasive aspergillosis. Detection of circulating Aspergillus DNA in the first positive galactomannan sample, with serial monitoring, could help in diagnosis of invasive aspergillosis in bone marrow transplant patients. Morbidity and mortality from aspergillosis can possibly be reduced if an early diagnosis is made and appropriate treatment initiated. An effective and accurate way of early detection of invasive aspergillosis is serial Aspergillus antigen monitoring.

Key Words: Aspergillus • galactomannan • bone marrow transplant

Journal of Pediatric Oncology Nursing, Vol. 23, No. 6, 300-304 (2006)
DOI: 10.1177/1043454206293260


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?